How to reduce EO residuals in medical devices

Instructor: Marisel Ortiz
Product ID: 701798
  • Duration: 60 Mins

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section

Training CD

One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-565-8542


Read Frequently Asked Questions

This Ethylene Oxide Sterilization Residuals regulation based webinar will provide a practical approach to fulfill requirements of the new ISO EO residual limits revised regulation.

Why Should You Attend:
The revision to ISO 10993-7:2008 Biological Evaluation of Medical Devices—Part 7: Ethylene Oxide Sterilization Residuals, significantly reduced the amount of residual EO or its by-products allowed to be left on Medical devices. The transition period defined to reach compliance with the new EO residual limits ends on October 2011. The new EO residual limits impose a tremendous challenge as it’s requires a significant investment of time, effort and capital in middle of a tough economic climate.

This webinar will offer ways to re-evaluate, re-design, or re-engineer your products, test methods and/or sterilization process to find opportunities for the simplest, fastest and most economical solutions to the problem. Additionally this webinar will offer ideas to transform a challenge into a potential opportunity for cost reduction. We will also discuss the practical approach to fulfill the regulation requirements.

Areas Covered in the Seminar:

  • Introduction.
    • Benefits/challenges
    • EO residual limits comparison
  • Factors influencing EO residuals
  • Product/Process Evaluation
    • Initial validation evaluation
    • Product /packaging/pallet configuration Evaluation
  • Process Re-engineering.
    • PCD/packaging/pallet modification
    • Lethality curve development
    • Aeration/Degassing Modification
    • Application of assumed transfer reduction factors
  • References.

Who Will Benefit:

This seminar is designed for professionals with responsibility for validating or making decisions related to the EO sterilization process
  • Sterilization/Quality Managers
  • Directors or VP
  • Quality or laboratory personnel
  • Chemists
  • Chemistry laboratory Managers
  • Validation specialists

Instructor Profile:
Marisel Ortiz, Over 24 years of management experience in the application of vanguard sterilization and microbiology technology. Experienced in: Quality System audits, CAPA, Ethylene Oxide (EO), Gamma Radiation, Steam autoclave, Biocompatibility program, Environmental controls, critical systems and laboratory operations, Cleaning/Disinfection/Sterilization of reusable products including cycle development, validation and routine monitoring processes. Recognized as the sterilization expert driving competitive advantage through innovative solutions that create greater value while maintaining full regulatory compliance. Renowned for uncompromised ethics and integrity. Strong educational background combining industrial microbiology, pre-medicine, and biology. Experience/training in CGMP, QSR, QSIT, ANSI/AAMI/ISO, DoH, EN, and OSHA regulations. Fluent in English and Spanish.

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
ComplianceOnline Medical Device Summit 2017

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed